According to Béjot et al. (2016), stroke is a devastating disease and approximately 1.1 million Europeans suffered a stroke each year. More than 80% of stroke survivors report one or more abnormal urinary symptoms at 3 or 12 months, with nocturia being the most frequent (Williams et al., 2012). Further, more than 50% of stroke survivors suffer from urinary incontinence in the acute stage; this value is reduced to 33% after 1 year (Kolominsky-Rabas et al., 2003). Urinary incontinence is defined as the complaint of any involuntary leakage of urine (Abrams et al., 2002). Urinary frequency, urgency and urge incontinence are the predominant symptoms in stroke survivors (Marinkovic & Badlani, 2001). Incontinence negatively affects the course of the disease; incontinent patients showed a worse functional outcome compared to continent patients (Pizzi et al., 2014).Urinary incontinence is a prognostic factor in the subacute phase after stroke for daily living activities (Meijer et al., 2003). Stroke survivors who are incontinent in the acute stage have a fourfold higher risk of institutionalization after a year, and urinary incontinence as initial presentation in acute stroke is associated with a high mortality rate (Kolominsky-Rabas et al., 2003;Marinkovic & Badlani, 2001).Urinary incontinence further negatively impacts the quality of life in persons with underlying neurologic conditions (Tapia et al., 2013).